Chembio Diagnostics Inc (NASDAQ:CEMI)
| 0.8638 Delayed Data As of Aug 12 |  +0.0085 / +1.00%Today’s Change | 0.42 Today|||52-Week Range 3.38 | -24.23% Year-to-Date |
Latest CEMI News | Press Releases
No recent news for Chembio Diagnostics Inc.
Today’s Trading
| Previous close | 0.85 |
| Today’s open | 0.85 |
| Day’s range | 0.82 - 0.87 |
| Volume | 502,184 |
| Average volume (3 months) | 634,442 |
| Market cap | $23.3M |
Data as of 3:53pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | -4.34% |
| Earnings growth (this year) | +35.71% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +47.27% |
| P/E ratio | NM |
| Price/Sales | 0.58 |
| Price/Book | 0.76 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACERAcer Therapeutics In... | -0.01 | -0.67% |
| AGEAgeX Therapeutics In... | -0.02 | -2.32% |
| ABEOAbeona Therapeutics ... | -0.23 | -4.94% |
| ---- |
Data as of 4:00pm ET, 08/12/2022
Financials
| Next reporting date | November 10, 2022 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $47.8M |
| Annual profit (last year) | -$33.9M |
| Net profit margin | -70.90% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Hauppauge, New York |
Forecasts
